Novaliq Email Formats

Pharmaceutical Manufacturing • Heidelberg, Baden-Württemberg, Germany • 21-50 Employees

Novaliq Email Formats

Novaliq uses 5 email formats. The most common is {first initial}{last name} (e.g., jdoe@novaliq.de), used 42.1% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@novaliq.de	52.6%
{first name}{last name}	johndoe@novaliq.com	42.2%
{last name}{last name}	doedoe@novaliq.de	5.3%

Key Contacts at Novaliq

Oliver Schlueter

Managing Director, Cfo

Kevin Schaaf

Director Controlling

Alice Meides

Director Clinical Development

Johannes Korward

Director Regulatory Affairs

Mathias Migneault

Director Corporate Development

Company overview

Headquarters	Im Neuenheimer Feld 515, Heidelberg, 69120, DE
Phone number	+49496221502590
Website	novaliq.com
NAICS	3254
SIC	283
Founded	2007
Employees	21-50
Socials

About Novaliq

Novaliq is a pharmaceutical company focusing on the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol®, the first water-free technology worldwide for ophthalmology products. With an initial focus on dry eye disease (DED), Novaliq offers an industry-leading portfolio addressing today’s unmet medical needs of millions of patients with eye disease. With an initial focus on dry eye disease (DED), Novaliq offers an industry-leading portfolio addressing today’s unmet medical needs of millions of patients with eye disease. NOV03 and CyclASol® are the two late stage development compounds. NOV03 is the first drug developed to treat evaporative DED associated with meibomian gland dysfunction in a highly effective way. CyclASol®, an ophthalmic solution of 0.1% cyclosporine A in EyeSol®, is an anti-inflammatory and immunomodulating drug for the treatment of aqueous deficient DED. Both compounds have shown superior clinical benefit, with an onset of action and an excellent tolerability profile. NovaTears® water-free eye drops for dry eye disease have CE certification and are commercialized in Australia/New Zealand by AFT Pharmaceuticals and in Europe as EvoTears® by Ursapharm. Novaliq is headquartered in Heidelberg, Germany and has an office in Cambridge, MA, USA. The long-term shareholder is dievini Hopp BioTech Holding, an active investor in Life and Health Sciences companies.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Vice President

Director

Entry

Employees by Department

Novaliq has 10 employees across 6 departments.

Departments

Number of employees

Funding Data

Explore Novaliq's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-05-12	1	$15,000,000

Funding Insights

$15,000,000

Total funding amount

$15,000,000

Most recent funding amount

Number of funding rounds

Novaliq Tech Stack

Discover the technologies and tools that power Novaliq's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

UIKit

UI frameworks

PHP

Programming languages

WP Rocket

Caching

WordPress

Blogs

IONOS

Hosting

MySQL

Databases

RSS

Miscellaneous

Priority Hints

Performance

Yoast SEO

SEO

Frequently asked questions

Novaliq is located in Heidelberg, Baden-Württemberg, DE.

You can reach Novaliq at +49496221502590.

Novaliq was founded in 2007, making it 19 years old. The company has established itself as a significant player in its industry over this time.

Novaliq has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Novaliq has raised a total of $15,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.